Skip to main content
OpenTrials
Completed

NCT Number: NCT02344771

Perioperative Endothelial Dysfunction

More than one in 100 otherwise healthy patients undergoing non-cardiac surgery will die within 30 days post-operatively, and of these patients 45% will die from vascular causes such as myocardial infarction. The pathogenesis of perioperative myocardial infarction is complex and to date not fully elucidated. The physiological stress response associated with the surgical procedure is believed to be central in the development of perioperative cardiovascular complications. Surgery initiates systemic inflammation, hypercoagulability and increases the production of catecholamines and cortisol. These drastic systemic changes lead to a state of myocardial oxygen supply-demand mismatch, which added to acute endothelial dysfunction and ruptures of vulnerable plaques, may result in myocardial injury.

The endothelium is a regulator of vascular homeostasis, vascular tone and structure and exerts anticoagulant, antiplatelet and fibrinolytic properties. Endothelial dysfunction is characterized by a decreased vascular bioavailability of nitric oxide probably due to an increased degradation of nitric oxide via its interaction with locally produced reactive oxygen species. No clinical studies have investigated whether peri- and postoperative endothelial dysfunction is associated with an increased risk of perioperative myocardial injury. Endothelial dysfunction may be a key element in the development of perioperative myocardial injury.

The aim of this observational clinical study is to closely examine the endothelial function and its dynamics in the early postoperative period.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Surgery, Roskilde Hospital

Roskilde, 4000, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients scheduled for elective colon cancer surgery

Exclusion criteria

  • Not capable of giving informed consent after oral and written information
  • Previously included in the trial
  • Surgery within 7 days of the trial

Treatment and study plan

Elective colon cancer surgery

Procedure

Primary outcomes

  1. Change from baseline endothelial function (reactive hyperemia index) at 4 days postoperatively

    Time frame: baseline before operation, 4 hours postoperatively and daily assessments day 1-4 after surgery.

    The reactive hyperemia index is assessed non-invasively by the EndoPat system.

Secondary outcomes

  1. Biomarkers of endothelial function: plasma arginine, plasma asymmetric dimethylarginine and plasma tetrahydrobiopterin

    Time frame: before surgery, 4 hours postoperatively and daily assessments on day 1-4 after surgery

  2. Biomarkers of endothelial glycocalyx degradation (syndecan-1, atrial natriuretic peptide)

    Time frame: before surgery, 4 hours postoperatively and daily assessments on day 1-4 after surgery.

  3. Plasma cardiac troponin I

    Time frame: before surgery and one daily assessment on day 1-4 after surgery.

Sponsors and collaborators

Lead sponsor

Zealand University Hospital

Other

Registry information

Official study title

Perioperative Endothelial Dysfunction in Patients Undergoing Non-cardiac Surgery

Important dates

Study start
2015
Primary completion
2015
Study completion
2015
First posted
Jan 26, 2015
Registry last updated
Feb 16, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.